A more predictive, preventive approach to medicine can enable more accurate population-level risk assessments and predictions ...

The Keck School of Medicine of USC and Keck Medicine of USC have launched collaborations with Tempus AI, Inc., a technology company at the forefront of applying AI to precision medicine, to integrate ...

First-of-its-kind digital pathology network powered by PathAI’s AISight® platform expands access to latest AI products, unlocks real-world data value, and fuels collaborative research with biopharma ...

The ArteraAI Prostate Test uses AI to analyze biopsy images, predicting hormone therapy benefits for prostate cancer patients. Approved in the US and UK, the test aids early diagnostic decisions, ...

Acurion, a precision oncology technology company developing AI-driven approaches to cancer biomarker detection, today announced that Co-Founder and Board Member Magda Marquet, Ph.D., will participate ...

Recent developments showcase major progress in genomics, AI-enabled biology, and gene therapy. From AI tools improving ...

A physician and Informatics expert makes the case for why doctors are needed more than ever even when AI tools outperform ...

Keck Medicine expands precision AI medicine to integrate genomic profiling and clinical trial matching across USC clinical network.

In a single day, major AI developments in healthcare ranged from a Keck Medicine–Tempus AI precision medicine partnership to OpenAI’s clinician-focused ChatGPT rollout and advances in AI-powered ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Thomas Fuchs, Dr.sc., Chief AI ...